Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Robert F. Kennedy Jr. Assures Vaccines Will Remain Available Under Trump Administration 
Lab-grown meat: you may find it icky, but it could drive forward medical research 
Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Akeso Secures U.S. Orphan Drug Status for Cancer Therapy Ligufalimab 
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life 
While some countries are already seeing progress in containing or the slowing down of the spread of the coronavirus, millions of people are still affected by COVID-19 elsewhere. As scientists ramp up efforts in developing a cure for COVID-19, a group of researchers has proposed a kind of vaccine that could be transmitted.
Express reports researchers have proposed developing a kind of vaccine that could be transmitted from person to person. Called “self-disseminating vaccines,” they explain that this kind of COVID-19 cure could potentially prevent transmission of coronaviruses between animals and humans. However, this unusual method also comes with risks, such as the possibility of an accidental mutation that could have a negative or fatal effect on humans and wildlife. This risk comes despite the method being economical.
This proposal was in a piece published in Nature magazine called “Self-disseminating vaccines to suppress zoonoses.” The authors of the piece noted how advances in genetic engineering can help solve health crises like this through vaccines that could be transmitted from one person to another.
According to the University of Idaho’s James J. Bull and Scott L. Nuismer, “It is now more apparent than ever that we need a better and more proactive approach,” in stopping coronavirus outbreaks. The two researchers also explain a kind of method of vaccines that could self-transmit through “wild animal reservoirs” to keep the disease from potentially infecting human populations. The downside to this method is that it could bring the original virus back to its harmful state among other “unintended” effects.
Previously, another group of researchers has made a breakthrough in finding a potential COVID-19 cure. Researchers from the University of Bristol led by Professor Christiane Schaffitzel of the School of Biology and Professor Imre Berger from the Max Planck Bristol Center for Minimal Biology found that the coronavirus has a “pocket” on its surface that could be injected with antiviral drugs. This would stop the virus before it even enters a human cell. They found that the virus makes use of a molecule called linoleic acid to bind itself to human cells, and from there it starts replicating.
With these findings, the researchers are now faced with a challenge of how to use this attribute of the virus against itself to end the pandemic.
